Pricing Log in Create free account

Alvotech (ALVO) vs HUTCHMED (China) Limited Sponsored ADR (HCM)

Alvotech and HUTCHMED (China) Limited Sponsored ADR are both Drug Manufacturers Specialty & Generic companies. HUTCHMED (China) Limited Sponsored ADR is the larger, with a market value of $2.5B against $1.8B — 1.4× the size. Alvotech grew revenue faster over the last twelve months: 364.3% against 245.2%. HUTCHMED (China) Limited Sponsored ADR has the higher net margin (−23.6% vs −101.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, HUTCHMED (China) Limited Sponsored ADR leads on 8 and Alvotech on 3.

Valuation

Metric ALVO HCM Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.45
P/S 4.83 n/m 2.11
P/B n/m n/m 1.69
Price to free cash flow n/m n/m 15.98
EV/EBITDA n/m 0.38 12.21
EV/Sales 8.79 (0.13) 2.79
Earnings yield (24.88%) (19.46%) (15.61%)
Free cash flow yield (14.95%) 0.00% 0.00%

Profitability

Metric ALVO HCM Drug Manufacturers Specialty & Generic median
Gross margin 42.71% 44.40% 53.51%
Operating margin (42.43%) 0.00% 0.00%
Net margin (101.05%) (23.63%) (2.31%)
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (0.80%)
Return on assets 0.00% 0.00% (1.67%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALVO HCM Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 364.29% 245.17% 5.22%
EPS growth (last fiscal year) 111.49% 1,090.91% 42.91%
Revenue growth, 5-year CAGR — 19.20% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALVO HCM Drug Manufacturers Specialty & Generic median
Debt to equity (6.82) 0.07 0.04
Current ratio 1.65 5.64 2.46
Net debt to EBITDA 9.71 49.29 1.01

Dividend

Metric ALVO HCM Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.47%
Payout ratio — — 0.28

Size

Metric ALVO HCM Drug Manufacturers Specialty & Generic median
Market cap 1.78b 2.48b 300.78m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack